KEY vs SRPT · P/E 13, rev $7.51B vs rev $1.90B
KeyCorp (KEY) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
KeyCorp (KEY) is a banks - regional company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported KEY revenue for 2025-12-31 was $7.51B. Net income was $1.83B. Revenue was up 62.7% from 2024-12-31 to 2025-12-31. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
KEY currently screens at market cap $22.64B and trailing P/E 12.8. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the KEY and SRPT stock pages for the full models.
Not investment advice.